MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Cognitive dysfunction"

  • 2019 International Congress

    Efficacy of Motor Imagery Questionnaire-RS as a Diagnostic Tool in Rehabilitation of Movement Disorders

    D. Kaur, N. Bhardwaj, S. Kumari, S. Kumari, A. Gupta, G. Kumar (Patna, India)

    Objective: The present study attempts to establish the normative reference value for motor imagery and compare it with patients with movement disorders. Background: Motor imagery,…
  • 2019 International Congress

    Cognitive event related potentials as biomarker of non-motor phenotypes in Parkinson’s Disease

    N. Koshel, S. Kryzhanovskyi, N. Karasevych, A. Pisaruk, I. Karaban (Kyiv, Ukraine)

    Objective: This research aimed to study the specific changes in cognitive event related potentials (ERP) in patients with different non-motor subtypes of Parkinson’s disease (PD).…
  • 2019 International Congress

    Puzzle resolution as cognitive test in Parkinson´s disease patients

    C. Borrue-Fernandez, D. Santos-García, J. Pagonabarraga, B. Pascual-Sedano, M. Mata, C. Study Group (Madrid, Spain)

    Objective: To analyze the value of puzzle resolution for cognitive testing in Parkinson´s disease patients. Background: Cognitive decline and dementia are common among Parkinson disease…
  • 2019 International Congress

    The Effects of Time-Varying Caloric Vestibular Stimulation Therapy on Cognition Impairment in Parkinson’s Disease

    K. Ade, A. Podlewska, S. Banducci, T. Pellat-Higgins, M. Bodani, M. Sakel, L. Smith, D. Attix, P. Lewitt, D. Wilkinson (Raleigh, NC, USA)

    Objective: To evaluate the potential efficacy of a software-controlled, solid-state, time-varying caloric vestibular stimulation (tvCVS) device for the treatment of cognitive impairment in Parkinson’s disease…
  • 2019 International Congress

    Semantic fluency impairment and amygdala atrophy are predictive factors for the development of Parkinson’s disease dementia

    O. Cousins, G. Pagano, J. Schulz, G. Dervenoulas, H. Wilson, S. Caminiti, S. Polychronis, M. Politis (London, United Kingdom)

    Objective: We investigated neuroanatomical differences between Parkinson’s disease (PD) patients with and without semantic fluency impairment and explored predictive markers for dementia development. Background: Sematic…
  • 2019 International Congress

    Mild Cognitive Impairment in Parkinson’s disease in South Indian population – Development of a test battery and assessment of prevalence and characteristics

    S. Krishnan Nair, R. Ramesh, G. Sarma, D. Puthenveedu, R. Menon, A. Kishore (Thiruvananthapuram, India)

    Objective: We aimed to design a neuropsychological test battery to diagnose Mild Cognitive Impairment (MCI) and to estimate the prevalence of MCI in Malayalam-speaking patients…
  • 2019 International Congress

    Plasma Soluble ST2 (sST2) levels are Higher in Neurodegeneration and Associate with PD Cognition

    ASL. Ng, YJ. Tan, ACW. Yong, BYX. Wong, ZH. Lu, SYE. Ng, SKS. Ting, S. Hameed, L. Zeng, N. Kandiah, WL. Au, LCS. Tan (Singapore, Singapore)

    Objective: As plasma IL-33 levels are too low to accurately quantify, we measured plasma sST2 as a surrogate marker for IL-33 in samples from healthy…
  • 2019 International Congress

    Introduction of an Assessment Toolkit Increases the Rate of DLB Diagnosis

    A. Surendranathan, J. Kane, A. Bentley, S. Barker, J. Taylor, A. Thomas, I. Mckeith, D. Burn, J. O'Brien (Cambridge, United Kingdom)

    Objective: To assess whether diagnostic rates of both Parkinson’s disease dementia (PDD) and dementia with Lewy bodies (DLB) could be increased by the introduction of…
  • 2019 International Congress

    Prospective Memory in Parkinson’s Disease: the role of the motor subtypes

    A. D'Iorio, G. Maggi, C. Vitale, D. Di Meglio, L. Trojano, G. Santangelo (Caserta, Italy)

    Objective: In the present study, we evaluated whether deficits in Prospective memory (PM) abilities were present to the same extent in tremor dominant patients with…
  • 2019 International Congress

    Imaging correlates of impaired self-awareness of cognitive deficits in Parkinson’s disease

    F. Maier, A. Greuel, M. Hoock, M. Tahmasian, F. Jessen, I. Csoti, L. Timmermann, C. Eggers (Cologne, Germany)

    Objective: To discover the neural basis of impaired self-awareness of cognitive deficits (ISA-cog) in Parkinson’s disease (PD) patients with mild cognitive impairment (MCI). Background: Anosognosia…
  • « Previous Page
  • 1
  • …
  • 73
  • 74
  • 75
  • 76
  • 77
  • …
  • 128
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley